Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v16-FR Version v5-FR
Language French French
Date Updated 2017-07-11 2017-04-06
Drug Identification Number 02182998 02182998
Brand name LEUCOVORIN CALCIUM INJECTION USP LEUCOVORIN CALCIUM INJECTION USP
Common or Proper name Levoleucovorin Calcium Levoleucovorin Calcium
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients LEUCOVORIN LEUCOVORIN
Strength(s) 10MG 10MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 x 50mL VIAL / AMPOULE
ATC code V03AF V03AF
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-03-14 2017-03-14
Actual start date 2017-04-05 2017-04-05
Estimated end date 2017-07-06 2017-04-28
Actual end date 2017-07-06
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments